Alkahest Management Team with Addition of César Cerezo as Chief Medical Officer
28 Jul 2021 //
GLOBENEWSWIRE
Alkahest to Present Positive Data at the AD/PD 2021
08 Mar 2021 //
GLOBENEWSWIRE
Alkahest Announces Peer-Reviewed Publication Demonstrating Safety and of GRF6019
28 Jan 2021 //
GLOBENEWSWIRE
Grifols to acquire Alkahest to enhance research for age-related diseases
07 Sep 2020 //
BIOSPACE
Grifols to acquire Alkahest to enhance discovery research and development
06 Sep 2020 //
PRNEWSWIRE
Alkahest Provides Corporate Update
09 Jul 2020 //
GLOBENEWSWIRE
Alkahest Announces Initiation of Phase 2 Study AKST1210-201 Exploring Treatment
01 Jun 2020 //
GLOBENEWSWIRE
Alkahest Initiates a Phase 2 Clinical Trial of AKST4290 in Parkinson’s Disease
04 Feb 2020 //
GLOBENEWSWIRE
Alkahest Initiates Phase 2 Clinical and Mechanistic Trial of AKST4290
17 Dec 2019 //
BIO SPACE